NM

New Medical Technologies

Europe, Basel-Stadt, Switzerland, Basel

Description

New Medical Technologies Management provides investment opportunities for all sectors of the emerging medical technology industries.

Investor Profile

New Medical Technologies has made 12 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series B (50%)
  • Series A (25%)
  • Series Unknown (8%)
  • Series D (8%)
  • Seed (8%)

Country Focus

  • Switzerland (58%)
  • United States (25%)
  • Canada (8%)
  • Germany (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Biopharma
  • Manufacturing
  • Medical Device
  • Hospital
  • Therapeutics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does New Medical Technologies frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
3i Group
Europe, England, United Kingdom, London
Co-Investments: 2
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 2
RBC Venture Partners
North America, Ontario, Canada, Toronto
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
Trudell Medical
Europe, England, United Kingdom, London
Co-Investments: 1
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
Alta Berkeley Venture Partners
Europe, England, United Kingdom, London
Co-Investments: 2
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 1
Aventic Partners
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2

What are some of recent deals done by New Medical Technologies?

Thommen Medical

Grenchen, Solothurn, Switzerland

Thommen Medical is developer & manufacturer of dental implantology products, Thommen Implant System.

Health CareManufacturingMedicalMedical Device
Series BMay 3, 2002
Thommen Medical

Grenchen, Solothurn, Switzerland

Thommen Medical is developer & manufacturer of dental implantology products, Thommen Implant System.

Health CareManufacturingMedicalMedical Device
Series ADec 14, 2001
Amount Raised: $3,677,507
PTC Therapeutics

South Plainfield, New Jersey, United States

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

BiotechnologyHealth CareTherapeutics
Series DSep 19, 2001
Amount Raised: $40,000,000
Spexis

Allschwil, Basel-Landschaft, Switzerland

Spexis is a swiss pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs.

BiotechnologyMedicalPharmaceutical
Series UnknownMay 2, 2001
Amount Raised: $9,250,004
Arpida AG

Reinach, Aargau, Switzerland

Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BOct 23, 2000
Amount Raised: $22,271,913
Ingenium Pharmaceuticals AG

Planegg, Bayern, Germany

Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.

Biotechnology
Series BOct 1, 2000
Amount Raised: $43,977,269
Cytos

Schlieren, Zurich, Switzerland

Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies .

BiotechnologyHospitalPharmaceutical
Series BJul 26, 2000
Amount Raised: $32,000,000
Viron Therapeutics

London, Ontario, Canada

Viron Therapeutics is a Biotechnology company

Biotechnology
Series AJan 19, 2000
Amount Raised: $7,317,000
Sunesis Pharmaceuticals

South San Francisco, California, United States

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.

BiotechnologyHealth CareOncologyPharmaceutical
Series BDec 6, 1999
Amount Raised: $25,200,000
Cytokinetics

South San Francisco, California, United States

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

BiopharmaBiotechnologyHealth Care
Series BOct 12, 1999
Amount Raised: $20,000,000